Pulse Biosciences, Inc (PLSE): Price and Financial Metrics


Pulse Biosciences, Inc (PLSE)

Today's Latest Price: $11.71 USD

0.63 (5.69%)

Updated Sep 25 4:00pm

Add PLSE to Watchlist
Sign Up

Overall POWR Rating

Sign Up to See Ratings...FREE!

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 138 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

PLSE Daily Price Range
PLSE 52-Week Price Range

PLSE Stock Price Chart Technical Analysis Charts

PLSE Price/Volume Stats

Current price $11.71 52-week high $16.30
Prev. close $11.08 52-week low $5.11
Day low $11.06 Volume 38,131
Day high $11.81 Avg. volume 108,569
50-day MA $10.79 Dividend yield N/A
200-day MA $10.28 Market Cap 295.23M

Pulse Biosciences, Inc (PLSE) Company Bio

Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.

Most Popular Stories View All

• When Does the Next Bull Run Start?

• Is Now a Good Time to Buy Shares of Carnival Corp.?

• 3 Dividend Stocks with EXPLOSIVE Growth

• Is eBay a Buy at $52?

• 4 DOWNGRADED Stocks to AVOID

View All Top Stories

PLSE Latest News Stream

Event/Time News Detail
Loading, please wait...
View All PLSE News

PLSE Latest Social Stream

Loading social stream, please wait...

View Full PLSE Social Stream

Latest PLSE News From Around the Web

Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.

Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE) a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to virtually participate in the upcoming H.C. Wainwright Global Investment Conference.

Yahoo | September 1, 2020

Mixed shelf roundup - healthcare

The following healthcare companies have filed for mixed shelf offerings:Pulse Biosciences (PLSE): $250M.ContraFect (CFRX): $150M.Larimar Therapeutics (LRMR): $200M....

Seeking Alpha | August 15, 2020

Pulse Biosciences, Inc. Appoints Richard van den Broek to Board of Directors

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a novel bioelectric medicine company progressing Nano-Pulse StimulationTM (NPS™) technology, announced today the appointment of Richard van den Broek to its board of directors. In connection with his appointment to the board, Mr. van den Broek will also serve as a member of the audit committee and the compensation committee of the Board.

Yahoo | August 6, 2020

Pulse Biosciences Schedules Second Quarter 2020 Financial Results Conference Call for August 10, 2020

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS™) technology, announced today it will report financial results for the second quarter 2020 after market close on Monday, August 10, 2020. Company management will host a corresponding conference call beginning at 1:30pm PT.

Yahoo | July 27, 2020

Nano-Pulse Stimulation™ Technology Produces Favorable Results in Several Clinical Studies Presented at the 2020 Laser Medicine and Surgery Virtual Annual Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS™) technology, today announced that three clinical studies demonstrating positive results across its dermatologic portfolio are available via webcast at the virtual annual conference of the American Society for Laser Medicine and Surgery (ASLMS). The virtual meeting went live on the ASLMS website on June 30, 2020. The clinical studies span the Company’s investigational use of NPS non-thermal energy in Nodular Basal Cell Carcinoma (BCC), Sebaceous Hyperplasia (SH) Lesions and Cutaneous Non-Genital Warts, along with e-Posters on pre-clinical observations of the effect of NPS energy on Murine Melanoma and Liver Tumors in situ.

Yahoo | July 1, 2020

Read More 'PLSE' Stories Here

PLSE Price Returns

1-mo 16.98%
3-mo 10.26%
6-mo 73.74%
1-year -25.08%
3-year -34.43%
5-year N/A
YTD -12.68%
2019 17.02%
2018 -51.44%
2017 263.08%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6613 seconds.